Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (7 quarters reported)
$164M in Q4 2024 → $213M now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| IQ Invesco Qqq Tr Put | 17.3% | New | 50,000 | $36.8M |
| Adma Biologics Inc | 12.8% | Added 1.7% | 3,262,542 | $27.3M |
| Palisade Bio Inc | 11.2% | Unchanged | 11,414,285 | $23.9M |
| Nrx Pharmaceuticals Inc | 7.9% | Added 36% | 4,091,767 | $16.7M |
| Faeth Therapeutics Inc | 7.2% | New | 610,169 | $15.3M |
| Taysha Gene Therapies Inc | 5.8% | Unchanged | 1,800,556 | $12.3M |
| PP Praxis Precision Medicines I | 5.2% | Unchanged | 33,237 | $11.1M |
| CS Cellectis S A | 4.6% | Unchanged | 3,281,501 | $9.84M |
| Zai Lab Ltd | 4.0% | Unchanged | 450,646 | $8.56M |
| Structure Therapeutics Inc | 3.5% | Added 9.8% | 140,000 | $7.51M |
| Oruka Therapeutics Inc | 3.4% | Unchanged | 75,000 | $7.14M |
| Iovance Biotherapeutics Inc | 2.9% | Unchanged | 1,500,000 | $6.24M |
| Spyre Therapeutics Inc | 2.9% | Trimmed 30% | 70,000 | $6.21M |
| Aura Biosciences Inc | 2.5% | Added 28% | 764,243 | $5.43M |
| Assembly Biosciences Inc | 2.3% | Unchanged | 175,706 | $4.83M |
| Bright Minds Biosciences Inc | 2.2% | Unchanged | 67,500 | $4.74M |
| UP Ultragenyx Pharmaceutical In | 2.1% | Unchanged | 135,000 | $4.51M |
| Sight Sciences Inc | 1.7% | Unchanged | 970,000 | $3.66M |
| Foghorn Therapeutics Inc | 0.5% | Added 96% | 200,000 | $976K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 6 quarters.
quarter ended June 30, 2026 · filed August 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IQ Invesco Qqq Tr | New | +50,000 | +$36.8M | 17.3% |
| Faeth Therapeutics Inc | New | +610,169 | +$15.3M | 7.2% |
| Nrx Pharmaceuticals Inc | Added | +1,091,767 | +$4.47M | 7.9% |
| Spyre Therapeutics Inc | Trimmed | −30,000 | −$2.66M | 2.9% |
| Aura Biosciences Inc | Added | +166,667 | +$1.18M | 2.5% |
| Structure Therapeutics Inc | Added | +12,500 | +$671K | 3.5% |
| Apogee Therapeutics Inc | Exited | −7,500 | −$631K | — |
| Foghorn Therapeutics Inc | Added | +98,000 | +$478K | 0.5% |
| Adma Biologics Inc | Added | +55,000 | +$460K | 12.8% |
| Soleno Therapeutics Inc | Exited | −7,500 | −$251K | — |
Showing the 10 largest of 11 changes.
quarter ended March 31, 2026 · filed May 15, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Palisade Bio Inc | Added | +6,914,285 | +$12.1M | 14.8% |
| Adma Biologics Inc | Added | +750,000 | +$6.76M | 21.4% |
| Nrx Pharmaceuticals Inc | New | +3,000,000 | +$6.39M | 4.7% |
| Bright Minds Biosciences Inc | New | +67,500 | +$4.93M | 3.7% |
| Structure Therapeutics Inc | Added | +37,500 | +$1.81M | 4.6% |
| Apogee Therapeutics Inc | Trimmed | −12,500 | −$1.05M | 0.5% |
| Zai Lab Ltd | Added | +50,646 | +$953K | 6.3% |
| Foghorn Therapeutics Inc | New | +102,000 | +$488K | 0.4% |
| Replimune Group Inc | Exited | −50,000 | −$486K | — |
| Soleno Therapeutics Inc | New | +7,500 | +$251K | 0.2% |
Showing the 10 largest of 13 changes.
quarter ended December 31, 2025 · filed February 17, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| EL Eli Lilly & Co | Exited | −22,500 | −$17.2M | — |
| Nvidia Corporation | Exited | −75,000 | −$14M | — |
| Akero Therapeutics Inc | Exited | −232,446 | −$11M | — |
| Palisade Bio Inc | New | +4,500,000 | +$10.6M | 7.8% |
| Structure Therapeutics Inc | New | +90,000 | +$6.26M | 4.6% |
| Nrx Pharmaceuticals Inc | Exited | −3,000,000 | −$4.46M | — |
| Apogee Therapeutics Inc | Trimmed | −15,000 | −$1.13M | 1.1% |
| Adma Biologics Inc | Added | +45,000 | +$821K | 33.1% |
| PP Praxis Precision Medicines I | Added | +1,737 | +$512K | 7.2% |
| GH Gamesquare Hldgs Inc | Exited | −250,000 | −$170K | — |
Showing the 10 largest of 12 changes.
quarter ended September 30, 2025 · filed November 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Insmed Inc | Trimmed | −154,842 | −$22.3M | — |
| EL Eli Lilly & Co | New | +22,500 | +$17.2M | 12.6% |
| Nvidia Corporation | New | +75,000 | +$14M | 10.3% |
| EL Eli Lilly & Co | Exited | −15,000 | −$11.7M | — |
| Nrx Pharmaceuticals Inc | New | +3,000,000 | +$4.46M | 3.3% |
| UP Ultragenyx Pharmaceutical In | Exited | −67,600 | −$2.46M | — |
| Adma Biologics Inc | Added | +95,000 | +$1.39M | 26.0% |
| UP Ultragenyx Pharmaceutical In | Added | +25,000 | +$752K | 3.0% |
| Assembly Biosciences Inc | Trimmed | −13,644 | −$349K | 3.3% |
| Spyre Therapeutics Inc | Added | +20,000 | +$335K | 1.2% |
Showing the 10 largest of 14 changes.
quarter ended June 30, 2025 · filed August 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| EL Eli Lilly & Co | New | +15,000 | +$11.7M | 9.0% |
| Insmed Inc | Trimmed | −107,500 | −$10.8M | 12.0% |
| UP Ultragenyx Pharmaceutical In | Added | +62,500 | +$2.27M | 3.1% |
| Biontech Se | Exited | −15,000 | −$1.37M | — |
| Taysha Gene Therapies Inc | Added | +545,000 | +$1.26M | 3.2% |
| UP Ultragenyx Pharmaceutical In | Added | +30,000 | +$1.09M | 1.9% |
| 89bio Inc | Exited | −95,623 | −$695K | — |
| PP Praxis Precision Medicines I | Added | +16,000 | +$673K | 1.1% |
| Aura Biosciences Inc | Added | +100,000 | +$626K | 2.8% |
| Akero Therapeutics Inc | Trimmed | −10,054 | −$536K | 9.5% |
Showing the 10 largest of 16 changes.
quarter ended March 31, 2025 · filed May 15, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IQ Invesco Qqq Tr | Exited | −110,000 | −$56.2M | — |
| Insmed Inc | Trimmed | −87,500 | −$6.68M | 17.2% |
| Iovance Biotherapeutics Inc | Added | +508,000 | +$1.69M | 4.3% |
| UP Ultragenyx Pharmaceutical In | Added | +39,904 | +$1.44M | 1.5% |
| Assembly Biosciences Inc | Added | +149,349 | +$1.43M | 1.6% |
| UP Ultragenyx Pharmaceutical In | New | +37,600 | +$1.36M | 1.2% |
| UP Ultragenyx Pharmaceutical In | Exited | −29,500 | −$1.24M | — |
| Biontech Se | Added | +11,500 | +$1.05M | 1.2% |
| PP Praxis Precision Medicines I | New | +19,000 | +$720K | 0.6% |
| Akero Therapeutics Inc | Trimmed | −17,500 | −$708K | 8.4% |
Showing the 10 largest of 20 changes.
Loading...
